A Phase Ib/ Ⅱ Clinical Study of MIL62 in Primary Membranous Nephropathy

NCT05398653 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Membranous Nephropathy

Interventions

DRUG: MIL62
DRUG: Cyclosporine
DRUG: MIL62

Sponsor

Beijing Mabworks Biotech Co., Ltd.